High serum level of 5-S-cysteinyldopa in chronic renal failure does not always indicate melanoma progression [7]

British Journal of Dermatology

Volumn 151, Issue 2, 2004, Pages 515-516

  Asada, Y ^a   Arakawa, S ^a   Fujiwara, S ^a   Sato, F ^a   Kaneda, K ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYSTEINYLDOPA;

ADULT; AGED; BLOOD LEVEL; CANCER GROWTH; CANCER STAGING; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; LETTER; MALE; MELANOMA; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CYSTEINYLDOPA; DISEASE PROGRESSION; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MELANOMA; MIDDLE AGED; SKIN NEOPLASMS;

EID: 4544221349     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2004.06096.x     Document Type: Letter

References (7)

1. Banfalvi T, Gilde K, Boldizsar M et al. Serum concentration of 5-S-cysteinyldopa in patients with melanoma. Eur J Clin Invest 2000; 30: 900-4.
2. Wakamatsu K, Kageshita T, Furue M et al. Evaluation of 5-S-cysteinyldopa as a marker of melanoma progression: 10 years' experience. Melanoma Res 2002; 12: 245-53.
3. Meyer T, Hauschild A, Kromminga A et al. Clinical evaluation of 5-S-cysteinyldopa testing using a new and optimized detection system as a tumour marker for malignant melanoma. Melanoma Res 2002; 12: 471-7.
4. Wakamatsu K, Ito S, Horikoshi T. Normal values of urinary excretion and serum concentration of 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2- carboxylic acid, biochemical markers of melanoma progression. Melanoma Res 1991; 1: 141-7.
5. Horikoshi T, Ito S, Wakamatsu K. Evaluation of melanin-related metabolites as markers of melanoma progression. Cancer 1994; 73: 629-36.
6. Kagedal B, Pettersson A. Determination of 5-S-L-cysteinyl-L-dopa in serum by high performance liquid chromatography after prepurification with immobilized boric acid. In: Pigment Cell. Biological, Molecular and Clinical Aspects of Pigmentation (Bagnara J, Kraus SMN, Paul E, Scherd M, eds), Tokyo: University of Tokyo Press, 1985: 721-7.
7. Agrup G, Andersson T, Falck B et al. 5-S-cysteinyldopa in the plasma of melanoma patients and the renal clearance of this amino acid. Acta Derm Venereol 1975; 55: 5-6.